J&J Gambles Oklahoma Opioid Trial Is Better Than Settlement; State Seeks $870m Per Year
Executive Summary
In opening statements, Oklahoma suggests award could be 'just shy of $13bn' if it takes 20 years to fix the problem.
You may also be interested in...
J&J Oklahoma Judgement May Set Benchmark For Massive Opioid Resolution
Judge orders J&J to pay $572m for one-year abatement plan; the state had proposed $12bn over 20-year period. J&J's gamble on a trial has so far not succeeded, since it is now facing more than twice the payout that Purdue agreed to in a settlement.
Behind-The-Scenes Battles As Opioid MDL Jury Trial Nears
Expert witness "battle plan," requests for summary judgment, and squabble over DEA drug distribution data offer preview of the first US bellwether trial against opioid manufacturers, distributors and pharmacies.
Endo And Allergan Could Edge Out Of Opioid Bellwether Trial Spotlight With Proposed Settlements
Companies reach agreements in principal with plaintiffs in bellwether trial in the US multidistrict litigation as court date nears; plaintiffs narrow their claims from 11 to seven.